These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire. Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ; Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149 [TBL] [Abstract][Full Text] [Related]
11. Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma. Mian I; Milton DR; Shah N; Nieto Y; Popat UR; Kebriaei P; Parmar S; Oran B; Shah JJ; Manasanch EE; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH; Bashir Q Cancer; 2016 Dec; 122(24):3831-3837. PubMed ID: 27680710 [TBL] [Abstract][Full Text] [Related]
12. [Maintenance therapies of thalidomine and interferon-α in multiple myeloma]. Li J; Cai JH; Huang BH; Liu JR; Zheng D Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(48):3417-20. PubMed ID: 22333255 [TBL] [Abstract][Full Text] [Related]
13. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial. Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621 [TBL] [Abstract][Full Text] [Related]
14. Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trial. Ho PJ; Brown RD; Spencer A; Jeffels M; Daniher D; Gibson J; Joshua DE Leuk Lymphoma; 2012 Sep; 53(9):1728-34. PubMed ID: 22329352 [TBL] [Abstract][Full Text] [Related]
15. T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden. Halapi E; Werner A; Wahlström J; Osterborg A; Jeddi-Tehrani M; Yi Q; Janson CH; Wigzell H; Grunewald J; Mellstedt H Eur J Immunol; 1997 Sep; 27(9):2245-52. PubMed ID: 9341766 [TBL] [Abstract][Full Text] [Related]
16. Recommend maintenance therapy with lenalidomide in multiple myeloma. Manasanch EE Semin Oncol; 2016 Dec; 43(6):712-713. PubMed ID: 28061994 [TBL] [Abstract][Full Text] [Related]
17. T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells. Raitakari M; Brown RD; Sze D; Yuen E; Barrow L; Nelson M; Pope B; Esdale W; Gibson J; Joshua DE Br J Haematol; 2000 Jul; 110(1):203-9. PubMed ID: 10930999 [TBL] [Abstract][Full Text] [Related]
18. Lenalidomide consolidation and maintenance therapy after autologous stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis. Clave E; Douay C; Coman T; Busson M; Bompoint C; Moins-Teisserenc H; Glauzy S; Carmagnat M; Gorin NC; Toubert A; Garderet L Leuk Lymphoma; 2014 Aug; 55(8):1788-95. PubMed ID: 24237448 [TBL] [Abstract][Full Text] [Related]
19. High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma. Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E Clin Transplant; 2009; 23(6):839-47. PubMed ID: 20447186 [TBL] [Abstract][Full Text] [Related]
20. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma. Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]